Nu Skin Enterprises, Inc.
NUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $3 |
| % Growth | -12% | -11.5% | -17.4% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 68.2% | 68.9% | 71.7% | 75% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $2 |
| Operating Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.8% | 2.5% | 5% | 8.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.5% | 0.4% | 4.7% | 5.5% |
| EPS | -2.95 | 0.17 | 2.1 | 2.93 |
| % Growth | -1,835.3% | -91.9% | -28.3% | – |
| EPS Diluted | -2.95 | 0.17 | 2.07 | 2.86 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -4.6% | 10.3% | 7.9% | 13.7% |